Clinical Trial Detail

NCT ID NCT01565837
Title Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wolfram Samlowski
Indications

melanoma

Therapies

Ipilimumab

Age Groups: adult

No variant requirements are available.